Primary Ocular Adnexal MALT Lymphoma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Primary Ocular Adnexal MALT Lymphoma trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06190301

RCT on Intralesional Rituximab Injection Versus ISRT in Ocular Adnexal MALT Lymphoma

This project proposes to establish a prospective, multicenter, randomized, controlled clinical study to compare the safety and efficacy of Intralesional Rituxim…

China108 participantsStarted 2023-12-20

Treatment: Rituximab, Involved Site Radiation Therapy

All recent trials (14 shown)

Not Yet RecruitingNot Applicable

NCT06064344

RCT of Intralesional Rituximab Injection Versus Involved Site Radiation Therapy in Ocular Adnexal MALT Lymphoma

This project proposes to establish a prospective, multicenter, randomized, controlled clinical study to compare the safety and efficacy of Intralesional Rituxim…

Location not specified108 participantsStarted 2023-10-07

Treatment: Rituximab, Involved Site Radiation Therapy

CompletedNot Applicable

NCT00899496

Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants

RATIONALE: Studying samples of blood and tissue in the laboratory from patients with cancer and from healthy participants may help doctors learn more about canc…

United States54 participantsStarted 2005-09

Treatment: immunological diagnostic method, physiologic testing

Primary Ocular Adnexal MALT Lymphoma

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RCT on Intralesional Rituximab Injection Versus ISRT in Ocular Adnexal MALT Lymphoma

All recent trials (14 shown)

RCT of Intralesional Rituximab Injection Versus Involved Site Radiation Therapy in Ocular Adnexal MALT Lymphoma

Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RCT on Intralesional Rituximab Injection Versus ISRT in Ocular Adnexal MALT Lymphoma

All recent trials (14 shown)

RCT of Intralesional Rituximab Injection Versus Involved Site Radiation Therapy in Ocular Adnexal MALT Lymphoma

Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants

Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma

BCX-1777 in Treating Patients With Refractory Cancer

Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Fo…

Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients

Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a St…

Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant S…

Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Relate…